Citation

Craig Hendrix, Joseph B. Margolick, Brent Gray Petty, Richard B. Markham, Lynda Nerhood, Homayoon Farzadegan, Paul O. Ts'o, Paul S. Lietman. Biologic effects after a single dose of poly(I):poly(C12U) in healthy volunteers. Antimicrobial Agents and Chemotherapy. 1993. 37: 429-35.

Citation

Brooks Jackson, Jamie Drew, Hsiang Ju Lin, Pat Otto, James W. Bremer, F. Blaine Hollinger, Steven M. Wolinsky. Establishment of a quality assurance program for human immunodeficiency virus type 1 DNA polymerase chain reaction assays by the AIDS Clinical Trials Group. ACTG PCR Working Group, and the ACTG PCR Virology Laboratories. Journal of Clinical Microbiology. 1993. 31: 3123-8.

Citation

Walter T. Hughes, David P. Jacobus, Craig Canfield, John Killmar. Anti-Pneumocystis carinii activity of PS-15, a new biguanide folate antagonist. Antimicrobial Agents and Chemotherapy. 1993. 37: 1417-9.

Citation

S. Srinivas, Ranga V. Srinivas, G. M. Anantharamaiah, R. W. Compans, J. P. Segrest. Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteins. Journal of Biological Chemistry. 1993. 268: 22895-9.

Citation

David M. Simpson, K. A. Citak, Ellen Godfrey, J. Godbold, D. E,. Wolfe. Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished?. Neurology. 1993. 43: 971-6.

Citation

Susan A. Fiscus, James D. Folds, Charles van der Horst. Infectious immune complexes in HIV-1-infected patients.. Viral Immunology. 1993. 6: 135-41.

Citation

Linda L. Rosendorf, Urania Dafni, David A. Amato, Barbara Lunghofer, John G. Bartlett, John M. Leedom, Diane W. Wara, John A. Armstrong, Catherine Godfrey, Eivind Sukkestad, Georg W. Counts. Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group. Controlled Clinical Trials. 1993. 14: 523-7.

Citation

Ross E. McKinney, J. W. Robertson. Effect of human immunodeficiency virus infection on the growth of young children. Duke pediatric AIDS clinical trials unit. Journal of Pediatrics. 1993. 123: 579-82.

Citation

F. Boucher. Phase I Evaluation of Zidovudine Adminstered to Infants Exposed at Birth to the Human Immunodeficiency Virus. Journal of Pediatrics. 1993. 122: 137-144.

Citation

Mary Jo O'Sullivan. The Pharmacokinetics and Safety of Zidovudine in the Third Trimester of Pregnancy for Women Infected With Human Immunodeficiency Virus and Their Infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group Study (Protocol 082). American Journal of Obstetrics and Gynecology. 1993. 168: 1510-1516.